MedPath

Explore research for osimertinib sensitivity in EGFR mutated non-small cell lung cancer; prospective observation study

Not Applicable
Conditions
EGFR mutated non-small cell lung cancer
Registration Number
JPRN-UMIN000043942
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients judged as inappropriate by the physician in charge

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association between treatment response with osimertinib treatment and patients background
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath